Literature DB >> 17541157

WRN functions in a RAD18-dependent damage avoidance pathway.

Yu Peng Dong1, Masayuki Seki, Akari Yoshimura, Eri Inoue, Shinya Furukawa, Shusuke Tada, Takemi Enomoto.   

Abstract

Werner syndrome (WS), caused by mutations in a gene (WRN) that encodes a RecQ DNA helicase, is characterized by premature aging and cancer predisposition. Cells derived from WS patients show sensitivity to several DNA damaging agents. Previous studies revealed that the WRN protein plays roles in DNA repair or damage tolerance, although it was not yet assigned to a specific pathway. Here we examined the relationship between WRN and the post-replication repair protein RAD18 by generating deletion derivatives in chicken DT40 cells. The frequency of spontaneous sister chromatid exchange in WRN(-/-)/RAD18(-/-) double mutant cells was slightly increased compared to that of either single mutant. However, the sensitivity of WRN(-/-)/RAD18(-/-) cells to 4-nitroquinoline 1-oxide and methyl methanesulfonate was almost the same as that of RAD18(-/-) cells. Moreover, the cisplatin sensitivity of RAD18(-/-) cells was slightly suppressed by disruption of WRN. These data suggest that WRN functions in a pathway involving RAD18 under damage-inducing conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541157     DOI: 10.1248/bpb.30.1080

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  7 in total

1.  The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.

Authors:  Federico Innocenti; Snezana Mirkov; Ramamoorthy Nagasubramanian; Jacqueline Ramírez; Wanqing Liu; Wasim K Bleibel; Sunita J Shukla; Kathleen Hennessy; Gary L Rosner; Edwin Cook; M Eileen Dolan; Mark J Ratain
Journal:  Cancer Chemother Pharmacol       Date:  2008-08-02       Impact factor: 3.333

2.  Pancreatic Adenocarcinoma Associated With Werner's Syndrome (Adult-Onset Progeria).

Authors:  Stephen G Chun; Nelson S Yee; John M Holland; Ralph V Shohet; Melvin P Palalay; Peter K Bryant-Greenwood
Journal:  Gastrointest Cancer Res       Date:  2011-01

Review 3.  The Werner's Syndrome RecQ helicase/exonuclease at the nexus of cancer and aging.

Authors:  Stephen G Chun; David S Shaeffer; Peter K Bryant-Greenwood
Journal:  Hawaii Med J       Date:  2011-03

4.  Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy.

Authors:  Stephen G Chun; Nelson S Yee
Journal:  Cancer Biol Ther       Date:  2010-09-22       Impact factor: 4.742

5.  WRN participates in translesion synthesis pathway through interaction with NBS1.

Authors:  Junya Kobayashi; Michiyo Okui; Aroumougame Asaithamby; Sandeep Burma; Benjamin P C Chen; Keiji Tanimoto; Shinya Matsuura; Kenshi Komatsu; David J Chen
Journal:  Mech Ageing Dev       Date:  2010-06-17       Impact factor: 5.432

6.  The Werner's Syndrome protein collaborates with REV1 to promote replication fork progression on damaged DNA.

Authors:  Lara G Phillips; Julian E Sale
Journal:  DNA Repair (Amst)       Date:  2010-08-05

Review 7.  Roles of the Werner syndrome RecQ helicase in DNA replication.

Authors:  Julia M Sidorova
Journal:  DNA Repair (Amst)       Date:  2008-09-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.